Please provide your email address to receive an email when new articles are posted on . FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress here, Terry Dagnon, ...
Please provide your email address to receive an email when new articles are posted on . This activity is supported by independent medical education grants from 4D Molecular Therapeutics; AbbVie Inc.; ...
An intravitreal implant (OTX-TKI) containing the tyrosine kinase inhibitor axitinib (Inlyta) was well tolerated and significantly reduced injection frequency by nearly 90% in patients with wet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results